127 related articles for article (PubMed ID: 37625387)
1. Discovery and Characterization of Moracin C as an Anti-Gouty Arthritis/Hyperuricemia Candidate by Docking-Based Virtual Screening and Pharmacological Evaluation.
Lv M; Jiang S; Deng S; Zhao Z; Yang Z; Liu L; Ke T
J Nat Prod; 2023 Sep; 86(9):2091-2101. PubMed ID: 37625387
[TBL] [Abstract][Full Text] [Related]
2. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
3. The Anti-hyperuricemia and Anti-inflammatory Effects of Atractylodes Macrocephala in Hyperuricemia and Gouty Arthritis Rat Models.
Qian X; Jiang Y; Luo Y; Jiang Y
Comb Chem High Throughput Screen; 2023; 26(5):950-964. PubMed ID: 35658881
[TBL] [Abstract][Full Text] [Related]
4. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice.
Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q
Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition.
Lu X; Zeng R; Lin J; Hu J; Rong Z; Xu W; Liu Z; Zeng W
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):277-284. PubMed ID: 31084401
[No Abstract] [Full Text] [Related]
7. Luteolin-4'-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models.
Lin Y; Liu PG; Liang WQ; Hu YJ; Xu P; Zhou J; Pu JB; Zhang HJ
Phytomedicine; 2018 Mar; 41():54-61. PubMed ID: 29519319
[TBL] [Abstract][Full Text] [Related]
8. Anti-Gouty Arthritis and Anti-Hyperuricemia Properties of
Sun Z; Li Z; Tan Y; Wang X; Wang C; Dong M; Liu H; Chen H; Li Y; Li L; Wang D
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297105
[TBL] [Abstract][Full Text] [Related]
9. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
[TBL] [Abstract][Full Text] [Related]
10. Termipaniculatones A-F, chalcone-flavonone heterodimers from Terminthia paniculata, and their protective effects on hyperuricemia and acute gouty arthritis.
Yang TH; Yan DX; Huang XY; Hou B; Ma YB; Peng H; Zhang XM; Chen JJ; Geng CA
Phytochemistry; 2019 Aug; 164():228-235. PubMed ID: 31181354
[TBL] [Abstract][Full Text] [Related]
11. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.
Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL
Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological basis for use of Lychnophora trichocarpha in gouty arthritis: anti-hyperuricemic and anti-inflammatory effects of its extract, fraction and constituents.
de Souza MR; de Paula CA; Pereira de Resende ML; Grabe-Guimarães A; de Souza Filho JD; Saúde-Guimarães DA
J Ethnopharmacol; 2012 Aug; 142(3):845-50. PubMed ID: 22732730
[TBL] [Abstract][Full Text] [Related]
13. Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
Wei H; Hu C; Xie J; Yang C; Zhao Y; Guo Y; Mei Z; Chen L; Lan Z
Eur J Pharmacol; 2014 Oct; 740():321-8. PubMed ID: 25064339
[TBL] [Abstract][Full Text] [Related]
14. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis.
Lemos Lima Rde C; Ferrari FC; de Souza MR; de Sá Pereira BM; de Paula CA; Saúde-Guimarães DA
J Ethnopharmacol; 2015 Feb; 161():194-9. PubMed ID: 25500302
[TBL] [Abstract][Full Text] [Related]
15. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators.
Dhanasekar C; Rasool M
Eur J Pharmacol; 2016 Sep; 786():116-127. PubMed ID: 27268719
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model.
Shi L; Liang T; Yang F; Zhu FF; Liu J; Jiang JQ; Wu XW; Chen AS; Yuan DP; Liang XL
Gene; 2021 Jan; 765():145120. PubMed ID: 32896590
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis.
Chen JS; Wang MX; Wang MM; Zhang YK; Guo X; Chen YY; Zhang MQ; Sun JY; Liu YF; Liu C
Eur J Med Chem; 2022 Jul; 237():114379. PubMed ID: 35468514
[TBL] [Abstract][Full Text] [Related]
18. Effects of evodiamine on ROS/TXNIP/NLRP3 pathway against gouty arthritis.
Cheng Y; Huang X; Tang Y; Li J; Tan Y; Yuan Q
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1015-1023. PubMed ID: 37555854
[TBL] [Abstract][Full Text] [Related]
19. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
[TBL] [Abstract][Full Text] [Related]
20. Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways.
Cheng JJ; Ma XD; Ai GX; Yu QX; Chen XY; Yan F; Li YC; Xie JH; Su ZR; Xie QF
Drug Des Devel Ther; 2022; 16():2119-2132. PubMed ID: 35812134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
